Detalles de la búsqueda
1.
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.
Int J Mol Sci
; 25(1)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203395
2.
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer.
Eur J Nucl Med Mol Imaging
; 49(11): 3878-3891, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562529
3.
Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments.
BMC Pulm Med
; 22(1): 5, 2022 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996404
4.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807876
5.
Non-small-cell lung cancer: how to manage BRAF-mutated disease.
Drugs Context
; 122023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37168877
6.
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cells
; 12(6)2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980174
7.
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center.
Heliyon
; 9(11): e21177, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37928020
8.
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics.
Cancers (Basel)
; 14(2)2022 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053513
9.
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives.
Expert Opin Biol Ther
; 22(10): 1259-1273, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994596
10.
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy.
Cancers (Basel)
; 14(20)2022 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291830
11.
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Cancers (Basel)
; 14(14)2022 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884472
12.
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
Front Oncol
; 11: 736123, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34631569
13.
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populations.
Immunotherapy
; 13(6): 509-525, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626932
14.
Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience.
Cancers (Basel)
; 13(7)2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33915801
15.
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.
Cancers (Basel)
; 13(13)2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34206545
16.
Radiomic Detection of EGFR Mutations in NSCLC.
Cancer Res
; 81(3): 724-731, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148663
17.
Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives.
Expert Rev Respir Med
; 14(4): 367-383, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31917616
18.
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium.
Expert Opin Pharmacother
; 21(6): 679-686, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073315
19.
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.
Cancers (Basel)
; 12(5)2020 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365882
Resultados
1 -
19
de 19
1
Próxima >
>>